Thomas R. Larson

439 total citations
9 papers, 320 citations indexed

About

Thomas R. Larson is a scholar working on Molecular Biology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Thomas R. Larson has authored 9 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Thomas R. Larson's work include Pneumonia and Respiratory Infections (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Thomas R. Larson is often cited by papers focused on Pneumonia and Respiratory Infections (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Thomas R. Larson collaborates with scholars based in United States, United Kingdom and Norway. Thomas R. Larson's co-authors include Janet Yother, Moon H. Nahm, Juan J. Calix, Ashok R. Venkitaraman, Mark Biffen, Denis R. Alexander, Chris Jones, Edward R. Zartler, Liewei Wang and Yuichi Machida and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Thomas R. Larson

8 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas R. Larson United States 8 173 90 70 48 46 9 320
Ana C. Maretti‐Mira United States 12 207 1.2× 92 1.0× 13 0.2× 167 3.5× 85 1.8× 20 472
Oscar Orozco Colombia 8 120 0.7× 69 0.8× 12 0.2× 26 0.5× 91 2.0× 15 319
Clara Suñer Spain 9 82 0.5× 88 1.0× 41 0.6× 21 0.4× 25 0.5× 14 250
Michael Sanford United States 7 55 0.3× 121 1.3× 28 0.4× 11 0.2× 191 4.2× 10 401
Michelle Chung United States 6 193 1.1× 129 1.4× 12 0.2× 27 0.6× 145 3.2× 9 458
Chengshui Chen China 8 53 0.3× 98 1.1× 33 0.5× 10 0.2× 37 0.8× 15 241
Andreas Schudy Germany 4 80 0.5× 128 1.4× 189 2.7× 12 0.3× 115 2.5× 5 348
Xiumin Huang China 9 108 0.6× 107 1.2× 11 0.2× 14 0.3× 29 0.6× 19 301
Adela Carrillo‐García Mexico 10 224 1.3× 90 1.0× 43 0.6× 6 0.1× 24 0.5× 15 354
Xiaopei Chao China 13 121 0.7× 104 1.2× 89 1.3× 10 0.2× 53 1.2× 24 387

Countries citing papers authored by Thomas R. Larson

Since Specialization
Citations

This map shows the geographic impact of Thomas R. Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas R. Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas R. Larson more than expected).

Fields of papers citing papers by Thomas R. Larson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas R. Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas R. Larson. The network helps show where Thomas R. Larson may publish in the future.

Co-authorship network of co-authors of Thomas R. Larson

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas R. Larson. A scholar is included among the top collaborators of Thomas R. Larson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas R. Larson. Thomas R. Larson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hanley, Michael J., Thomas R. Larson, Paul M. Diderichsen, et al.. (2025). Population Pharmacokinetic and Exposure–Response Analyses for Ponatinib in the Phase 3 PhALLCON Study. Clinical and Translational Science. 18(3). e70175–e70175.
2.
Skolnik, Jeffrey, David Hall, Donald A. Barkauskas, et al.. (2021). Toxicity and pharmacokinetics of actinomycin-D and vincristine in children and adolescents: Children’s Oncology Group Study ADVL06B1. Cancer Chemotherapy and Pharmacology. 88(2). 359–365. 7 indexed citations
3.
Barreto, Jason N., Joel M. Reid, Carrie A. Thompson, et al.. (2021). Prospective evaluation of high‐dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function. Clinical and Translational Science. 15(1). 105–117. 12 indexed citations
4.
Kurmi, Kiran, Jia Yu, Felix Boakye‐Agyeman, et al.. (2018). Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway. Cell Metabolism. 28(6). 833–847.e8. 47 indexed citations
5.
Larson, Thomas R. & Janet Yother. (2017). Streptococcus pneumoniae capsular polysaccharide is linked to peptidoglycan via a direct glycosidic bond to β-D- N -acetylglucosamine. Proceedings of the National Academy of Sciences. 114(22). 5695–5700. 36 indexed citations
6.
Larson, Thomas R., B Cauliez, Fabrice Bauer, et al.. (2016). Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients. PLoS ONE. 11(8). e0159914–e0159914. 13 indexed citations
7.
Jones, Chris, Thomas R. Larson, Juan J. Calix, et al.. (2013). Streptococcus pneumoniae Serotype 11D Has a Bispecific Glycosyltransferase and Expresses Two Different Capsular Polysaccharide Repeating Units. Journal of Biological Chemistry. 288(30). 21945–21954. 31 indexed citations
8.
Calix, Juan J., et al.. (2012). Biochemical, Genetic, and Serological Characterization of Two Capsule Subtypes among Streptococcus pneumoniae Serotype 20 Strains. Journal of Biological Chemistry. 287(33). 27885–27894. 125 indexed citations
9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana C. Maretti‐Mira Breakdown of academic impact, for papers by Oscar Orozco Breakdown of academic impact, for papers by Clara Suñer Breakdown of academic impact, for papers by Michael Sanford Breakdown of academic impact, for papers by Michelle Chung Breakdown of academic impact, for papers by Chengshui Chen Breakdown of academic impact, for papers by Andreas Schudy Breakdown of academic impact, for papers by Xiumin Huang Breakdown of academic impact, for papers by Adela Carrillo‐García Breakdown of academic impact, for papers by Xiaopei Chao
Rankless by CCL
2026